Morgan Stanley reports 7.8% stake in Nuveen S&P 500
Nuveen S&P 500 Dynamic Overwrite Fund shows that Morgan Stanley and Morgan Stanley Smith Barney LLC reported beneficial ownership positions representing 7.8% of the fund's common shares as of 03/31/2026.
Rhea-AI Filing Summary
Nuveen S&P 500 Dynamic Overwrite Fund shows that Morgan Stanley and Morgan Stanley Smith Barney LLC reported beneficial ownership positions representing 7.8% of the fund's common shares as of 03/31/2026. The filing lists shared dispositive power of 10,765,257 shares (Morgan Stanley) and 10,741,193 shares (Morgan Stanley Smith Barney LLC) and identifies the issuer by CUSIP 6706EW100. The Schedule 13G is a joint filing by the two MS reporting units and includes exhibits for a joint filing agreement and Item 7 subsidiary information. Signatures are dated 05/12/2026.
Positive
- None.
Negative
- None.
Insights
Large passive holding disclosed: MS reports a ~7.8% position in the fund.
Morgan Stanley and Morgan Stanley Smith Barney LLC jointly report beneficial ownership representing 7.8% of the common shares with shared dispositive counts of 10,765,257 and 10,741,193 respectively, per the cover data dated 03/31/2026.
The filing is a Schedule 13G joint report indicating aggregated reporting by MS reporting units and references Exhibit 99.2 for subsidiary identification; timing and cash‑flow treatment are not stated in the excerpt.
Filing follows passive/aggregated reporting rules for institutional holders.
The schedule cites Release No. 34-39538 and states the numbers reflect MS Reporting Units; the joint filing and Item 7 exhibit are attached for subsidiary classification. The signature blocks show authorised signatories dated 05/12/2026.
Regulatory implications are procedural: the disclosure provides investor transparency on large holdings; the filing does not state trading intent or transactional details.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
Joint Filing Agreement regulatory
FAQ
What stake did Morgan Stanley report in Nuveen S&P 500 Dynamic Overwrite Fund (SPXX)?
Which securities and identifier are disclosed in the Schedule 13G for SPXX?
When were the ownership figures and signatures dated in the filing?
Does the Schedule 13G say whether Morgan Stanley is an active or passive holder?
What exhibits accompany the joint Schedule 13G filing for SPXX?
AI-generated analysis. How Rhea-AI works. Not financial advice.